New research confirms that both Tai Chi and cognitive behavioral therapy can reduce insomnia in breast cancer survivors but also may provide additional health benefits by reducing inflammation and bolstering anti-viral defenses.
New research led by UCLA Health confirms that both tai chi and cognitive behavioral therapy can reduce insomnia in breast cancer survivors but also may provide additional health benefits by reducing inflammation and bolstering anti-viral…
Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition. This clinical longitudinal observational study explored…
Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition.
Join Team Robyn’s Red Breasts in celebrating resilience and raising cancer awareness with their unique woollen boob adornments at the Nello cycle event
Shannen Doherty has both positive and difficult news to share about her cancer journey. During Monday’s new episode of her podcast Let’s Be Clear, the Beverly Hills, 90210 alum gave fans an update on her Stage 4 breast cancer battle — and…
Get latest articles and stories on Latest News at LatestLY. Chinese smartphone maker Xiaomi on Tuesday announced its partnership with former Indian cricketer Yuvraj Singh's foundation YouWeCan to launch a breast cancer screening initiative…
Roisin Pelan was told she had just three years to live - six years ago. Since then, the entrepreneur from Preston has defied the odds and fulfilled a string of ambitions.
Earlier this year, Northeastern University researchers unveiled a web-based artificial intelligence tool designed to diagnose prostate cancer at a faster and more accurate rate.
The Beverly Hills, 90210 star was diagnosed with stage 4 breast cancer in 2020, and has since provided her loyal fans with updates on her health journey on her podcast Let’s Be Clear
Researchers from Oxford and Cambridge have developed a new tool to identify these anti-cancer cells which could lead to improved, personalised and therefore better immunotherapies.